FOSPHENYTOIN vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSPHENYTOIN vs OSIMERTINIB: Safety Overview
| Metric | FOSPHENYTOIN | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 1,378 | 27,750 |
| Deaths Reported | 166 | 12,456 |
| Death Rate | 12.0% | 44.9% |
| Hospitalizations | 646 | 5,277 |
| Average Patient Age | 37.5 yrs | 68.2 yrs |
| % Female Patients | 52.4% | 66.0% |
| FDA Approval Date | Aug 5, 1996 | Nov 13, 2015 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | AstraZeneca Pharmaceuticals LP |
| Route | INTRAMUSCULAR | ORAL |
| Marketing Status | Prescription | Prescription |